Morgan Stanley Milestone Pharmaceuticals Inc. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,969,067 shares of MIST stock, worth $6.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,969,067

Previous 820,421 261.9%

Holding current value

$6.12 Million

Previous $1.59 Million 271.34%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$1.38 - $2.56 $2.97 Million - $5.5 Million	2,148,646 Added 261.9%	2,969,067 $5.91 Million
Q2 2025 Aug 15, 2025	SELL	$0.65 - $1.96 $96,267 - $290,283	-148,104 Reduced 15.29%	820,421 $1.59 Million
Q1 2025 May 15, 2025	SELL	$0.8 - $2.41 $256,492 - $772,684	-320,616 Reduced 24.87%	968,525 $774,000
Q4 2024 Feb 14, 2025	BUY	$1.43 - $2.36 $530,285 - $875,156	370,829 Added 40.38%	1,289,141 $3.04 Million
Q3 2024 May 14, 2025	BUY	$1.29 - $1.65 $115,658 - $147,935	89,658 Added 10.82%	918,312 $1.4 Million

Q3 2024 Nov 14, 2024	BUY	$1.29 - $1.65 $115,658 - $147,935	89,658 Added 10.82%	918,312 $1.4 Million
Q2 2024 May 14, 2025	SELL	$1.29 - $1.83 $594,028 - $842,691	-460,487 Reduced 35.72%	828,654 $1.09 Million
Q2 2024 Oct 17, 2024	BUY	$1.29 - $1.83 $11,385 - $16,151	8,826 Added 1.08%	828,654 $1.09 Million
Q2 2024 Aug 14, 2024	BUY	$1.29 - $1.83 $11,385 - $16,151	8,826 Added 1.08%	828,654 $1.09 Million
Q1 2024 Oct 17, 2024	SELL	$1.4 - $2.2 $12,356 - $19,417	-8,826 Reduced 1.07%	819,828 $1.47 Million
Q1 2024 Aug 16, 2024	BUY	$1.4 - $2.2 $182,599 - $286,941	130,428 Added 18.92%	819,828 $1.47 Million
Q1 2024 May 15, 2024	BUY	$1.4 - $2.2 $182,599 - $286,941	130,428 Added 18.92%	819,828 $1.47 Million
Q4 2023 Aug 16, 2024	SELL	$1.67 - $3.39 $232,554 - $472,071	-139,254 Reduced 16.8%	689,400 $1.15 Million
Q4 2023 Feb 13, 2024	SELL	$1.67 - $3.39 $18,730 - $38,022	-11,216 Reduced 1.6%	689,400 $1.15 Million
Q3 2023 Nov 15, 2023	SELL	$2.68 - $3.69 $279,853 - $385,320	-104,423 Reduced 12.97%	700,616 $2.17 Million
Q2 2023 Aug 14, 2023	SELL	$2.85 - $4.4 $93,525 - $144,390	-32,816 Reduced 3.92%	805,039 $2.29 Million
Q1 2023 May 15, 2023	SELL	$3.14 - $4.2 $1.55 Million - $2.07 Million	-492,333 Reduced 37.01%	837,855 $3.3 Million
Q4 2022 Feb 14, 2023	BUY	$3.53 - $9.5 $317,399 - $854,192	89,915 Added 7.25%	1,330,188 $5.27 Million
Q3 2022 Nov 14, 2022	SELL	$5.86 - $9.43 $456,494 - $734,597	-77,900 Reduced 5.91%	1,240,273 $11.4 Million
Q2 2022 Oct 27, 2022	BUY	$5.13 - $7.37 $2.56 Million - $3.68 Million	499,533 Added 61.02%	1,318,173 $8.11 Million
Q2 2022 Aug 15, 2022	BUY	$5.13 - $7.37 $2.56 Million - $3.68 Million	499,533 Added 61.02%	1,318,173 $8.11 Million
Q1 2022 Oct 27, 2022	SELL	$4.1 - $8.24 $2.05 Million - $4.12 Million	-499,533 Reduced 37.9%	818,640 $5.26 Million
Q1 2022 May 13, 2022	SELL	$4.1 - $8.24 $30,159 - $60,613	-7,356 Reduced 0.89%	818,640 $5.26 Million
Q4 2021 Feb 14, 2022	SELL	$5.47 - $7.13 $150,786 - $196,545	-27,566 Reduced 3.23%	825,996 $5.41 Million
Q3 2021 Nov 15, 2021	BUY	$5.28 - $6.29 $4.51 Million - $5.37 Million	853,562 New	853,562 $4.87 Million

Others Institutions Holding MIST

# of Institutions

Shares Held

38.4M

Call Options Held

111K

Put Options Held

270K

View Full List

About Milestone Pharmaceuticals Inc.

Ticker MIST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,010,900
Market Cap $61.8M
Description
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...

More about MIST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account